Abstract:The interactions between antithrombin III (ATIII), thrombin, and surface immobilized heparin were investigated. Carboxylated polystyrene modified with covalently immobilized albumin-heparin conjugate contain sites which can bind ATIII from buffer and plasma solutions. Approximately 65% of the ATIII molecules present at the heparinized surface either adsorbed from a buffer or plasma solution, exchanged with ATIII in buffer solution. The exchange between surface bound ATIII and ATIII in solution was repeated several times on the same heparinized surface. The number of binding sites that could bind and release ATIII was much higher when the heparinized surface was exposed to an ATIII containing buffer solution than to a plasma solution. The reduction in binding sites available for ATIII using plasma solutions as compared to buffer solutions could be explained by the competition of other plasma proteins with ATIII for the heparinized surface. It was observed that heparin binding proteins were able to compete with ATIII for binding to the immobilized heparin. Furthermore adsorption of proteins on the heparinized surface significantly reduced the availability of binding sites for ATIII. Exposure of thrombin to the heparinized surface resulted in thrombin activity at the surface. The thrombin activity on the heparinized surfaces was lower on surfaces with a higher ATIII concentration. The activity of surface bound thrombin was not affected by the presence of other plasma proteins. Enzymatically active thrombin molecules present at the heparinized surface were completely inactivated when the surface was exposed to a solution containing ATIII. The inactivation rate of surface bound thrombin by ATIII was higher than the rate of the uncatalyzed inactivation of thrombin in solution. Part of the Thrombin-Antithrombin III (TAT) complexes (10-20%) that were formed upon inactivation of thrombin remained bound to the heparinized surface. In general it was concluded that only the surface immobilized heparin molecules that can bind ATIII in a reversible way determine the anticoagulant properties of the surface. The mechanism of inactivation of a protease on a heparinized surface depends either on the catalytic effect of heparin on the inactivation rate of proteases by ATIII or on an increased uncatalytic inactivation due to increased concentrations of ATIII near the surface as compared to the concentration of ATIII in the bulk phase.

Antithrombin–S195A factor Xa‐heparin structure reveals the allosteric mechanism of antithrombin activation

Structure of the antithrombin–thrombin–heparin ternary complex reveals the antithrombotic mechanism of heparin

Helix D Elongation and Allosteric Activation of Antithrombin

Molecular Mechanisms of the Impaired Heparin Pentasaccharide Interactions in 10 Antithrombin Heparin Binding Site Mutants Revealed by Enhanced Sampling Molecular Dynamics

Structural Analysis of Heparin-Derived 3-O-sulfated Tetrasaccharides: Antithrombin Binding Site Variants.

Structural Determinants For Heparin Binding In Human Coagulation Factor Xi

Inhibition of platelet-surface-bound proteins during coagulation under flow II: Antithrombin and heparin

Thrombin activation of the factor XI dimer is a multistaged process for each subunit

Hydrolysis of Heparinase Ⅰ to SyntheticHeparin-Pentasaccharide and Effecton Its Anti-factor Xa Activity

Experimental proof for the structure of a thrombin-inhibiting heparin molecule

The Interactions Between Antithrombin III, Thrombin and Surface Immobilized Heparin

Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia

Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation

Physiological significance of antithrombin D-helix interaction with vascular GAGs

TFPIα anticoagulant function is highly dependent on protein S in vivo

Differential Solvent DEEP-STD NMR and MD Simulations Enable the Determinants of the Molecular Recognition of Heparin Oligosaccharides by Antithrombin to Be Disentangled

Regulation of thrombin activity with a bifunctional aptamer and hemin: development of a new anticoagulant and antidote pair.

Structure–Function Relationship of the Interaction between Tissue Factor and Factor VIIa

Binding Modes of Prothrombin Cleavage Site Sequences to the Factor Xa Catalytic Triad: Insights from Atomistic Simulations

Kinetics and regulation of coagulation factor X activation by intrinsic tenase on phospholipid membranes

Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition Through a Template Mechanism